Author:
Kanagalingam Suthasenthuran,Ul Haq Zargham,Victory Srinivasan Nishok,Khan Aujala Irfan,Mashat Ghadi D,Hazique Mohammad,Khan Kokab Irfan,Ramesh Prasana,Khan Safeera
Reference29 articles.
1. Centers for disease control and prevention. An update on cancer deaths in the United States. (2022). Accessed: July 31, 2022: https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths.
2. National Cancer Institute. Non-small cell lung cancer treatment (PDQ®)-health professional version. (2022). Accessed: July 31, 2022: https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq.
3. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC: Final overall survival analysis of CTONG1104 phase III trial;Zhong WZ;J Clin Oncol,2021
4. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw P;J Thorac Oncol,2016
5. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update;Bethune G;J Thorac Dis,2010
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献